Literature DB >> 21314329

Upregulation of p53 expression in patients with colorectal cancer by administration of curcumin.

Zhen-Yu He1, Chuan-Bing Shi, Hao Wen, Fang-Long Li, Bao-Lin Wang, Jie Wang.   

Abstract

Biological therapies can be beneficial in cancer patients. The present study aims to examine the inhibitory mechanism of curcumin on cancer cells in patients with colorectal cancer. The results showed that curcumin administration increased body weight, decreased serum TNF-alpha levels, increased apoptotic tumor cells, enhanced expression of p53 molecule in tumor tissue, and modulated tumor cell apoptotic pathway. We conclude that the curcumin treatment improves the general health of patients with colorectal cancer via the mechanism of increased p53 molecule expression in tumor cells and consequently speeds up tumor cell apoptosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21314329     DOI: 10.3109/07357907.2010.550592

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  68 in total

Review 1.  Role of phytochemicals in colorectal cancer prevention.

Authors:  Yu-Hua Li; Yin-Bo Niu; Yang Sun; Feng Zhang; Chang-Xu Liu; Lei Fan; Qi-Bing Mei
Journal:  World J Gastroenterol       Date:  2015-08-21       Impact factor: 5.742

Review 2.  Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases.

Authors:  Ajaikumar B Kunnumakkara; Devivasha Bordoloi; Ganesan Padmavathi; Javadi Monisha; Nand Kishor Roy; Sahdeo Prasad; Bharat B Aggarwal
Journal:  Br J Pharmacol       Date:  2016-10-21       Impact factor: 8.739

3.  Curcumin induces apoptosis through mitochondrial pathway and caspases activation in human melanoma cells.

Authors:  Ai-Jun Jiang; Guan Jiang; Lian-Tao Li; Jun-Nian Zheng
Journal:  Mol Biol Rep       Date:  2014-09-28       Impact factor: 2.316

Review 4.  Therapeutic roles of curcumin: lessons learned from clinical trials.

Authors:  Subash C Gupta; Sridevi Patchva; Bharat B Aggarwal
Journal:  AAPS J       Date:  2012-11-10       Impact factor: 4.009

Review 5.  Role of nuclear factor κB-mediated inflammatory pathways in cancer-related symptoms and their regulation by nutritional agents.

Authors:  Subash C Gupta; Ji Hye Kim; Ramaswamy Kannappan; Simone Reuter; Patrick M Dougherty; Bharat B Aggarwal
Journal:  Exp Biol Med (Maywood)       Date:  2011-05-12

6.  Curcumin improves treatment outcome of Takayasu arteritis patients by reducing TNF-α: a randomized placebo-controlled double-blind clinical trial.

Authors:  Nan Shao; Huixin Jia; Yiwen Li; Jingying Li
Journal:  Immunol Res       Date:  2017-08       Impact factor: 2.829

7.  Recent Advances of Curcumin and its Analogues in Breast Cancer Prevention and Treatment.

Authors:  Charlotta D Mock; Brian C Jordan; Chelliah Selvam
Journal:  RSC Adv       Date:  2015-09-02       Impact factor: 3.361

8.  FLLL12 induces apoptosis in lung cancer cells through a p53/p73-independent but death receptor 5-dependent pathway.

Authors:  Abedul Haque; Mohammad A Rahman; James R Fuchs; Zhuo Georgia Chen; Fadlo R Khuri; Dong M Shin; A R M Ruhul Amin
Journal:  Cancer Lett       Date:  2015-04-24       Impact factor: 8.679

Review 9.  Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers.

Authors:  Bharat B Aggarwal; Subash C Gupta; Bokyung Sung
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

10.  Curcumin induces apoptosis in p53-null Hep3B cells through a TAp73/DNp73-dependent pathway.

Authors:  Jinhong Wang; Hai Xie; Feng Gao; Tingkun Zhao; Hongming Yang; Bai Kang
Journal:  Tumour Biol       Date:  2015-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.